The CFB gene helps make factor B, a protein that helps your immune system recognize germs and clear damaged material. This gene plays an important role in keeping the complement system, a rapid immune defense process, active but controlled. If the gene does not work as expected, this response can become too weak or too active, which may contribute to some kidney conditions or to age related macular degeneration, an eye condition that affects central vision. Most CFB variants have little effect, while a smaller number are linked to disease risk.
What is a gene?
A gene is a stretch of DNA with instructions that cells use to make molecules or regulate activities in the body. Some genes provide the directions for proteins, which do the cell’s work. Others mainly guide when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence your response to food, stress, and medications. For a closer look at this topic, you can learn more in the LearnHub.
Overview
CFBGene function
What if the gene works
The CFB gene helps make factor B, a blood protein that supports the complement system, part of your immune defense. It helps your body mark germs for removal and amplify inflammation when needed.
Risk
What if the gene does not work
Changes in the CFB gene can disrupt complement, part of immune defense. More severe variants may cause recurrent bacterial infections, while others can raise the risk of a rare kidney condition or age-related macular degeneration; effects vary.
Treatment
What does that mean for your treatment
No CFB-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the CFB gene. The CFB gene is an active drug target in complement medicine, and factor B inhibitors are being studied or used for some complement-driven conditions based on the disease itself, not simply on carrying a CFB variant.
Conditions associated with CFB
Gene function
What if the gene works
Each day, your blood carries proteins that help spot germs early and clean up damaged material. Among them, the CFB gene provides instructions for factor B, a key part of the complement system, a fast acting part of immunity. This helps explain how the CFB gene supports the immune system during routine infections and tissue cleanup.
Factor B helps the complement system switch on quickly when it meets germs or damaged material. It joins other immune proteins on a target surface so your body can respond without waiting for antibodies.
After activation, factor B becomes part of a protein team that cuts more complement proteins into active pieces. This creates an amplifying loop, so immune tagging spreads efficiently across a microbe's surface.
This process helps coat bacteria and other targets with complement markers, making them easier for immune cells to recognize and clear. It also supports later complement steps that attract immune cells and can damage some bacterial outer membranes.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variations in appearance, metabolism, or how the body reacts to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CFB gene can change the factor B protein’s shape, stability, or ability to bind its partners, which explains how CFB gene variants affect protein function in cells. Some variants reduce secretion or weaken formation of the protein complex that amplifies complement activity, while others make that complex more active or harder to control. This spectrum ranges from milder changes with small functional effects to more disruptive variants that can be linked to earlier or stronger complement related disease.
How variants are linked to conditions
Rare pathogenic variants in the CFB gene can cause atypical hemolytic uremic syndrome, a rare condition that can affect the kidneys and blood cells. Some variants in the CFB gene have also been linked to C3 glomerulopathy, another rare kidney condition. In studies on the CFB gene and age-related macular degeneration, certain common variants are associated with a higher or lower chance of the eye disease rather than a diagnosis on their own.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Risk with CFB depends on the specific gene change. For common CFB changes linked to age-related macular degeneration, older age, smoking, and family history can further raise risk. For rare CFB changes tied to complement-related kidney illness, infections, pregnancy, and some medicines can act as triggers.
Inheritance of CFB variants
How CFB variants are inherited depends on the specific condition linked to the variant. Rare CFB deficiency is inherited in an autosomal recessive pattern, so a child usually needs to inherit one changed copy of the CFB gene from each parent. Some CFB-related kidney conditions, including complement-mediated atypical hemolytic uremic syndrome and C3 glomerulopathy, can follow an autosomal dominant pattern, where one changed copy may be enough to increase risk. This means the inheritance of CFB gene variants is not described by one single pattern for every CFB-related condition.
What does my CFB result mean for my family?
For families, the meaning of a CFB result depends on the condition linked to that specific change. Some CFB changes are tied to a dominant pattern, so close relatives may also carry the same change and may wish to discuss testing. Other CFB-related conditions follow a recessive pattern, which means relatives may be healthy carriers without having symptoms.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CFB gene variants uses a blood or saliva sample to read the gene’s DNA code and look for changes. Results can show whether you carry a variant linked to certain kidney or eye conditions, although doctors interpret the finding alongside your symptoms and family history.
When should I consider getting a genetic test?
Consider genetic testing for the CFB gene if you or close relatives have had a rare kind of sudden kidney injury with low blood counts and small blood clots (atypical hemolytic uremic syndrome) or another inherited kidney condition linked to an overactive immune pathway. Testing can help show whether a CFB change may be involved and can support family counseling.
A genetic result is only one part of your health story
Genetic findings can be informative, but the amount they reveal varies with the condition and the specific kind of variant. Over time, factors like age, environment, lifestyle, and medical history also influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic result can offer a clear explanation. In areas like medication response, these results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences shape a person’s response to medicines. It studies relationships between genes and medications to clarify why the same treatment can affect people differently. With many drugs, genes help determine both how strong the effect is and how the body handles the medicine. This information can support treatment choices that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CFB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
Research on the CFB gene grew out of mid 20th century work on the complement system, a part of the immune response found in blood. In recent decades, awareness of this gene’s role has grown as scientists mapped the major histocompatibility complex on chromosome 6, where the CFB gene sits alongside several other immune related genes. Factor B was identified as a key blood protein before the gene itself was fully characterized, which was common in early human genetics. Building on this early work, scientists linked CFB variants to differences in complement activity and later to conditions such as age related macular degeneration. As genetic testing improved, CFB became part of broader efforts to understand how inherited immune differences shape disease risk. Its history is mainly a scientific one, tied to the wider story of modern immunology and complement research.